NCT03439293 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- groups
- description
- Ixazomib, 4 mg, capsules, orally, on Days 1, 8 and 15 of each 28-day cycle along with daratumumab, 16 mg/kg, intravenously (IV), on Days 1, 8, 15 and 22 of Cycles 1 and 2, on Days 1 and 15 (every 2 weeks) for Cycles 3 to 6 and on Day 1 (every 4 weeks) for Cycle 7 and beyond along with dexamethasone, 20 mg, tablets, orally on Days 1, 2, 8, 9, 15, 16, 22 and 23 of each 28-day cycle until progressive disease (PD), unacceptable toxicity, or withdrawal of consent, or up to 5 years.
- id
- BG000
- title
- Ixazomib 4 mg + Daratumumab 16 mg/kg + Dexamethasone 20 mg
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.80
- value
- 67.8
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Female
- measurements
- group Id
- BG000
- value
- 32
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 55
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 5
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 53
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 5
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.71
- value
- 166.8
- denoms
- counts
- group Id
- BG000
- value
- 60
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Number analyzed is the number of participants with data available for height at Baseline.
- title
- Height
- unit Of Measure
- centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 17.625
- value
- 80.08
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kilograms (kg)
- population Description
- Safety population included participants who received at least 1 dose of any study treatment regimen.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- groups
- description
- Ixazomib, 4 mg, capsules, orally, on Days 1, 8 and 15 of each 28-day cycle along with daratumumab, 16 mg/kg, intravenously (IV), on Days 1, 8, 15 and 22 of Cycles 1 and 2, on Days 1 and 15 (every 2 weeks) for Cycles 3 to 6 and on Day 1 (every 4 weeks) for Cycle 7 and beyond along with dexamethasone, 20 mg, tablets, orally on Days 1, 2, 8, 9, 15, 16, 22 and 23 of each 28-day cycle until progressive disease (PD), unacceptable toxicity, or withdrawal of consent, or up to 5 years.
- id
- BG000
- title
- Ixazomib 4 mg + Daratumumab 16 mg/kg + Dexamethasone 20 mg
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.80
- value
- 67.8
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Female
- measurements
- group Id
- BG000
- value
- 32
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 55
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 5
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 53
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 5
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.71
- value
- 166.8
- denoms
- counts
- group Id
- BG000
- value
- 60
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- Number analyzed is the number of participants with data available for height at Baseline.
- title
- Height
- unit Of Measure
- centimeters (cm)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 17.625
- value
- 80.08
- denoms
- counts
- group Id
- BG000
- value
- 61
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kilograms (kg)
- population Description
- Safety population included participants who received at least 1 dose of any study treatment regimen.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle